Always stunned me that NWBO never ran a solo L trial to prove it could stand alone.
>>Although current therapies provide 5-year overall survival of approximately 95%, patients who receive chemotherapy often have multiple relapses or progressions and worsening of functional decline, including visual impairment and hypothalamic dysfunction. In addition, radiation is associated with the risk of long-term neurologic and cognitive impairments and is therefore generally reserved for older patients after less toxic treatments have been exhausted.
News 
Market Data 
Discover 
